博迅生物
(920504)
| 流通市值：3.10亿 | | | 总市值：7.86亿 |
| 流通股本：1709.19万 | | | 总股本：4333.31万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 59,246,977.51 | 26,599,005.35 | 119,810,751.55 | 84,576,132.64 |
| 营业总成本 | 52,386,955.98 | 24,273,581.88 | 107,019,235.22 | 75,863,313.61 |
| 其他经营收益 | | | | |
| 营业利润 | 7,679,435.32 | 1,742,639.91 | 16,747,348.86 | 10,066,365.73 |
| 利润总额 | 7,679,671.48 | 1,742,876.07 | 16,336,245.58 | 9,668,471.39 |
| 净利润 | 6,906,235.15 | 1,495,622.01 | 14,914,704.14 | 8,543,763.95 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 6,906,235.15 | 1,495,622.01 | 14,914,704.14 | 8,543,763.95 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 169,493,777.87 | 163,957,724.81 | 171,677,640.37 | 151,506,224.11 |
| 非流动资产: | | | | |
| 非流动资产合计 | 87,005,173.97 | 98,374,181.11 | 99,682,154.61 | 103,529,931.13 |
| 资产总计 | 256,498,951.84 | 262,331,905.92 | 271,359,794.98 | 255,036,155.24 |
| 流动负债: | | | | |
| 流动负债合计 | 33,063,766.41 | 35,658,453.38 | 46,211,887.45 | 34,994,896.47 |
| 非流动负债: | | | | |
| 非流动负债合计 | 18,789,272.23 | 18,771,532.48 | 18,741,609.48 | 20,005,900.91 |
| 负债合计 | 51,853,038.64 | 54,429,985.86 | 64,953,496.93 | 55,000,797.38 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 204,645,913.2 | 207,901,920.06 | 206,406,298.05 | 200,035,357.86 |
| 股东权益合计 | 204,645,913.2 | 207,901,920.06 | 206,406,298.05 | 200,035,357.86 |
| 负债和股东权益合计 | 256,498,951.84 | 262,331,905.92 | 271,359,794.98 | 255,036,155.24 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 41,016,180.91 | 11,324,417.81 | 115,269,940.91 | 61,234,288.78 |
| 经营活动现金流出小计 | 53,780,981.02 | 24,749,263.98 | 94,723,025.36 | 64,751,219.34 |
| 经营活动产生的现金流量净额 | -12,764,800.11 | -13,424,846.17 | 20,546,915.55 | -3,516,930.56 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 160,414,416.89 | 77,343,759.7 | 329,980,566.24 | 229,808,342.95 |
| 投资活动现金流出小计 | 194,607,836.59 | 106,582,722.59 | 348,410,396.4 | 258,328,348.29 |
| 投资活动产生的现金流量净额 | -34,193,419.7 | -29,238,962.89 | -18,429,830.16 | -28,520,005.34 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 8,666,620 | - | 2,826,303 | 2,279,999 |
| 筹资活动产生的现金流量净额 | -8,666,620 | - | -2,826,303 | -2,279,999 |
| 汇率变动对现金及现金等价物的影响 | -23,820.18 | -23,198.22 | 964.76 | 9,877.3 |
| 现金及现金等价物净增加额 | -55,648,659.99 | -42,687,007.28 | -708,252.85 | -34,307,057.6 |
| 期末现金及现金等价物余额 | 20,076,218.34 | 33,037,871.05 | 75,724,878.33 | 42,126,073.58 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -55,648,659.99 | - | -708,252.85 | - |